Oliver Curme

Portfolio · 1

Efranat Pharma

Anticancer Immunotherapy Treatment

1 round $4.5M committed Latest: 2014-11

Investment activity

Q&A

What is Oliver Curme's primary investment focus by sector?

Oliver Curme has concentrated investments in the Health Tech & Life Sciences sector, with one recorded investment in this area.

Can you name a notable company in Oliver Curme's portfolio?

A notable company in Oliver Curme's portfolio is Efranat Pharma, which focuses on anticancer immunotherapy treatment.

What is the most recent investment activity recorded for Oliver Curme?

Oliver Curme's most recent recorded investment activity was in November 2014, with one investment round completed that month.

What funding stage does Oliver Curme typically invest in?

Oliver Curme has made one recorded investment at the Seed funding stage.

What was the funding amount for Efranat Pharma?

Efranat Pharma raised $4.5M in a round where Oliver Curme participated.